Latest News and Press Releases

Did BellRing Brands, Inc. Mislead Investors about its Inventory Levels? Contact BFA Law about the Pending Securities Fraud Class Action

MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...

Inaugural WorldWiDE EdTech Awards winners announced, honoring innovative learning solutions. Nominations for 2027 open Sep. 1, 2026.

TRUNNANO achieves key breakthrough in reaction sintered silicon carbide ceramics, enhancing performance for extreme industrial applications.

Le rilzabrutinib de Sanofi a été désigné comme thérapie innovante aux États-Unis et comme médicament orphelin au Japon pour le traitement de l’anémie hémolytique auto-immune à anticorps chauds Le...

The US and Japan granted breakthrough therapy/orphan status to rilzabrutinib for wAIHA, a rare blood disorder marked by the destruction of red blood cells

WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice Geneva, Switzerland, February 9, 2026 – WISeKey International Holding Ltd...

Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.